Edition:
United Kingdom

Agilent Technologies Inc (A.N)

A.N on New York Stock Exchange

72.19USD
18 Jan 2018
Change (% chg)

$0.13 (+0.18%)
Prev Close
$72.06
Open
$72.20
Day's High
$72.50
Day's Low
$71.69
Volume
388,103
Avg. Vol
504,183
52-wk High
$72.50
52-wk Low
$47.05

Select another date:

Thu, Jan 18 2018

BRIEF-Agilent Technologies Board Increases Size From 11 To 12 Members

* AGILENT TECHNOLOGIES INC SAYS ON JANUARY 17, BOARD INCREASED ITS SIZE FROM 11 TO 12 MEMBERS -SEC FILING Source text: (http://bit.ly/2EVj4Zh) Further company coverage:

BRIEF-Agilent Expands Cell Analysis Portfolio With Acquisition Of Luxcel Biosciences

* AGILENT EXPANDS CELL ANALYSIS PORTFOLIO WITH ACQUISITION OF LUXCEL BIOSCIENCES

BRIEF-Agilent Technologies Q4 non-gaap earnings per share $0.67

* Agilent Technologies reports fourth-quarter fiscal year 2017 financial results

BRIEF-Agilent technologies increases cash dividend to 14.9 cents per share

* Agilent technologies increases cash dividend to 14.9 cents per share Source text for Eikon: Further company coverage:

BRIEF-Agilent Technologies receives expanded FDA approval for Dako PD-L1 IHC 22C3 pharmDx

* Agilent Technologies receives expanded FDA approval for the use of Dako PD-L1 IHC 22C3 pharmDx companion diagnostic in gastric or gastroesophageal junction (GEJ) cancer Source text for Eikon: Further company coverage:

BRIEF-Agilent Technologies announces sponsorship deal with LabCentral

* Announced platinum sponsorship agreement with LabCentral, co to equip LabCentral's shared laboratory workspace with co's technology​

BRIEF-Agilent announces expanded use of cancer diagnostic in U.S.

* Says ‍FDA approved cancer diagnostic for use in cases of UC and of Squamous Cell Carcinoma of head & neck​ Source text for Eikon: Further company coverage:

BRIEF-AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY

* AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY

BRIEF-Agilent Technologies files lawsuit against Shanghai Echrom Electronic and former employees

* FILED A CIVIL LAWSUIT AGAINST SHANGHAI ECHROM ELECTRONIC TECHNOLOGY CO LTD AND SEVERAL FORMER EMPLOYEES OF AGILENT

BRIEF-Agilent Technologies reports Q3 non-GAAP earnings per share of $0.59

* Agilent Technologies reports third-quarter fiscal year 2017 financial results

Select another date: